Isolated hepatic perfusion in the pig with TNF-α with and without melphalan

British Journal of Cancer

Volumn 75, Issue 10, 1997, Pages 1447-1453

  Borel Rinkes, I H M ^a,e   De Vries, M R ^a   Jonker, A M ^b   Swaak, T J G ^a   Hack, C E ^c   Nooyen, P T G A ^d   Wiggers, T ^a   Eggermont, A M M ^a  

^a ERASMUS MC CANCER INSTITUTE   (Netherlands)

^b Laboratory of Pathology   (Netherlands)

^c CENTRAL LABORATORY   (Netherlands)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^e UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Isolation; Liver; Metastases; Perfusion; Tumour necrosis factor

Indexed keywords

DEXTRAN; MELPHALAN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CATHETER; CONTROLLED STUDY; DRUG TOLERABILITY; HEPATIC ARTERY; INFERIOR CAVA VEIN; LIVER PERFUSION; LIVER TOXICITY; NONHUMAN; PORTAL VEIN; PRIORITY JOURNAL; REGIONAL PERFUSION; SWINE;

EID: 0030953617     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1997.248     Document Type: Article

References (53)

1. Aigner KR, Walther H, Tonn JC, Wenzl A, Merker G and Schwemmle K (1982) Die isolierte Leberperfusion mit 5-Fluorouracil (5-FU) beim Menschen. Chirurg 53: 571-573
2. Aigner KR (1988) Isolated liver perfusion: 5-year results. Reg Cancer Treat 1: 11-20
3. Alexander RB and Rosenberg SA (1991) Tumour necrosis factor: clinical application. In Biologic Therapy of Cancer, De Vita Jr VT, Hellman S and Rosenberg SA. (eds), pp. 378-392. JB Lippincott: Philadelphia.
4. Archer SG and Gray BN (1989) Vascularization of small liver metastases. Br J Surg 76: 545-548
5. Asher A, Mule JJ, Reichert CM, Shipant E and Rosenberg SA (1987) Studies on the anti-tumor efficacy of systemically administered recombinant tumor necrosis factor against several murine tumors in vivo. J Immunol 138: 963-974
6. Bengmark S and Hafstrom L (1969) The natural history of primary and secondary tumours of the liver. I. The prognosis for patients with hepatic metastases from colonic and renal carcinoma by laparotomy. Cancer 23: 198-202
7. Blick M, Sherwin SA, Rosenblum M and Gutterman J (1987) Phase I study of recombinant tumor necrosis factor in cancer patients. Cancer Res 47: 2986-2989
8. Boddie AW Jr, Booker L, Mullins JD, Buckley CJ and McBride CM (1979) Hepatic hyperthermia by total isolation and regional perfusion in vivo. J Surg Res 26: 447-457
9. Busam KJ, Baver TM, Baver J, Gerok W and Decker K (1990) Interleukin-6 release by rat liver macrophages. J Hepatol 11: 367-373
10. Cady B and Stone M (1991) The role of surgical resection of liver metastases in colorectal carcinoma. Semin Oncol 18: 4399-406
11. Canellos GP (1987) The case for high-dose chemotherapy: is it chemotherapy's last gamble? Eur J Cancer Clin Oncol 23: 351-355
12. Chang AE, Schneider PD, Sugarbaker PH, Simpson C, Culnane M and Steinberg SM (1987) A prospective randomized trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases. Ann Surg 206: 685-693
13. Cid MC, Kleinman HK, Grant DS, Schnaper HW, Favci AS and Hoffman GS (1994) Estradiol enhances leucocyte binding to tumor necrosis factor (TNF)-stimulated endothelial cells via an increase in TNF-induced adhesion molecules E-selectin, intercellular adhesion molecule type 1, and vascular cell adhesion molecule type 1. J Clin Invest 93: 17-25
14. De Brauw LM, Van De Velde CJH, Tjaden UR, De Bryijn EA, Bell AURJ, Hermans J and Zwaveling A (1988) In vivo isolated liver perfusion technique in a rat hepatic metastasis model: 5-fluorouracil concentrations in tumor tissue. J Surg Res 44: 137-145
15. De Takats PG, Kerr DJ, Poole CJ, Warren HW and McArdle CS (1994) Hepatic arterial chemotherapy for metastatic colorectal carcinoma (review). Br J Cancer 69: 372-378
16. Eggermont AMM, Schraffordt Koops H, Lienard D, Kroon BBR, Van Geel AN, Hoekstra HJ and Lejeune FJ (1994) High-dose Tumor Necrosis Factor-α in combination with Interferon-γ and Melphalan in isolated perfusion of the limb for irresectable soft tissue sarcomas: a highly effective approach to achieve limb salvage. In Cytokines in Cancer Therapy, Bergmann L and Mitrou PS. (eds), pp. 81-88. Contrib Oncol Vol. 46. Karger: Basle
17. Eggermont AMM, Schraffordt Koops H, Lienard D, Kroon BBR, Van Geel AN, Hoekstra HJ and Lejeune FJ (1996a). Isolated limb perfusion with high dose tumor necrosis factor-α in combination with IFNγ- and melphalan for irresectable extremity soft tissue sarcomas: a multicenter trial. J Clin Oncol 14: 2653-2665
18. Eggermont AMM, Schraffordt Koops H, Klausner J, Kroon BBR, Schlag PM, Lienard D, Van Geel AN, Hoekstra HJ, Meller I, Nieweg OE, Kettelhack C, Ben-Ari G, Pector JC and Lejeune FJ (1996b) Isolated limb perfusion with tumor necrosis factor-a and melphalan in 186 patients with locally advanced extremity sarcomas: the cumulative multicentre European experience. Ann Surgery 224: 756-765
19. Feinberg B, Kurzrock R, Talpa ZM, Blick M, Saks S and Gutterman JU (1988) A phase I trial of intravenously administered recombinant tumor necrosis factor in patients with advanced cancer. J Clin Oncol 6: 1328-1334
20. Frei E and Canellos GP (1980) Dose: a critical factor in cancer chemotherapy. Am J Med 69: 585-594
21. Genari L (1992) Liver metastases: a many-sided therapeutical problem. Hepatogastroenterology 39: 5-9
22. Greenway B (1988) Hepatic metastases from colorectal cancer: resection or not. Br J Surg 75: 513-551
23. Hafstrom LR, Holmberg SB, Nazedi PL, Bengtsson A, Tidebrandt G and Schertsen TS (1994) Isolated hyperthermic liver perfusion with chemotherapy for liver malignancy. Surg Oncol 3: 103-108
24. Hughes KS, Simon R, Songhorabodj S, Adson MA, Ilstrup DM, Fortner JG, Maclean BJ, Foster JH, Daly JM, Fitzherbert D and Sugarbalrer PH (1986) Resection of the liver for colorectal carcinoma metastases: a multiinstitutional study of patterns of recurrence. Surgery 100: 278
25. Jaattela M (1991) Biologic activities and mechanisms of action of tumor necrosis factor α/ cachectin. Lab Invest 64: 724-742
26. Kahky MP, Daniel CO, Cruz AB and Gaskill III HV (1990) Portal infusion of tumor necrosis factor increases mortality in rats. J Surg Res 49: 138-145
27. Kemeny N (1983) The systemic chemotherapy of hepatic metatases. Semin Oncol 10: 148-155
28. Kemeny N, Daly J, Reichman B, Geller N, Botet J and Oderman P (1987) Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma. Ann Int Med 107: 459-465
29. Leighton TA Averbook AW, Klein SR and Bongard FS (1991) Time-course of cardiopulmonary effects of tumor necrosis factor and endotoxin are similar. Am Surg 57: 836-842
30. Lienard D, Eggermont AMM, Schraffordt Koops H, Kroon BBR, Rosen Kaimer F, Autier P and Lejeune FJ (1994) Isolated perfusion of the limb with high-dose tumour necrosis factor-alpha (TNF-α), interferon-gamma (IFN-γ) and melphalan for melanoma stage III. Results of a multi-center pilot study. Melanoma Res 4: 21-26
31. Marinelli A, Van Dierendonck JH, Van Brakel GM, Irth H, Kuppen PJK, Tjaden VR and Van De Velde CJH (1991) Increasing the effective concentration of melphalan in experimental rat liver tumours: comparison of isolated liver perfusion and hepatic artery infusion. Br J Cancer 64: 1069-1075
32. Mavligit GM, Zukiwskj AA, Charnsangavej C, Carrasco CH, Wallace S and Gutterman GM (1992) Hepatic arterial infusion with human tumor necrosis factor in patients with liver metastases. Cancer 69: 557-561
33. Pentecost MJ (1993) Transcatheter treatment of hepatic metastases. Am J Roentgenol 160: 1171-1175
34. Que FG and Nagorney DM (1994) Resection of 'recurrent' colorectal metastases to the liver. Br J Surg 81: 255-258
35. Radnell M, Jeppsson B and Bengmark S (1990) A technique for isolated liver perfusion in the rat with survival and results of cytotoxic drug perfusion on liver tumor growth. J Surg Res 49: 394-399
36. Renard N, Lienard D, Lespagnard L, Eggermont A, Heimann R and Lejeune F (1994) Early endothelium activation and polymorphonuclear cell invasion precede specific necrosis of human melanoma and sarcoma treated by intravascular high-dose tumour necrosis factor alpha (rTNFα). Int J Cancer 57: 656-663
37. Scheele J, Strangl R and Altendorf-Hofmann A (1990) Hepatic metastases from colorectal carcinoma: impact of surgical resection on the natural history. Br J Surg 77: 1241-1246
38. Shirahama M, Ishibasi H, Tsuchiya Y, Kurokawa S, Okomura Y and Niho Y (1988) Kinetics and parameters of the induction of interleukin-1 secretion by rat Kupffer cells. J Clin Lab Immunol 27: 127-132
39. Sidhu RS and Bollon AP (1993) Tumor necrosis factor activities and cancer therapy - a perspective. Pharmac Ther 57: 79-128
40. Sindelar WF (1985) Isolation-perfusion of the liver with 5-fluorouracil. Ann Surg 201: 337-343
41. Skibba JL and Condon RE (1983) Hyperthermic isolation perfusion in vivo of the canine liver. Cancer 51: 1303-1309
42. Skibba JL, Quebbeman EJ, Komorowski RA and Thorsen KM (1988) Clinical results of hyperthermic liver perfusion for cancer in the liver. Contr Oncol 29: 222-228
43. Starzl TA (1990) Liver transplantation: a 30-year perspective. Part I. Curr Probl Surg 27: 73-76
44. Strangl R, Altendorf-Hofman A, Charnley RM and Scheele J (1994) Factors influencing the natural history of colorectal liver metastases. Lancet 343: 1405-1410
45. Strohmeyer T, Haugeberg G and Lierse W (1986) Vaskularisation von Lebermetastasen: eine korrosionsanatomische Studie. Acta Anat 126: 172-176
46. Sugihara K, Hojo K, Moriya Y, Yamasaki S, Kosuget and Takayama T (1993) Pattern of recurrence after hepatic resection for colorectal metastases. Br J Surg 80: 1032-1035
47. Sullivan RD, Norcoss JW and Watkins E (1964) Chemotherapy of metastatic liver cancer by prolonged hepatic artery infusion. N Engl J Med 270: 321-327
48. Truog WE, Gibson RL, Henderson WR, Redding GJ and Standaert TA (1992) Effect of pentoxifylline on cytokine- and eicosanoid-induced acute pulmonary hypertension in piglets. Pediatr Res 31: 163-169
49. Van De Velde CJH, Kothuis BJL, Barenbrug HWM, Jongejan N, Runia RD, De Brauw LM and Zwaveling A (1986) A successful technique of in vivo isolated liver perfusion in pigs. J Surg Res 41: 593-599
50. Van Der Schelling GP, Ijzermans JNM, Kok TC, Schering M, Marquet RL, Splinter TAW and Jeekel J (1992) A phase I study of local treatment of liver metastases with recombinant tumor necrosis factor. Eur J Cancer 28A: 1073-1078
51. Van Ooijen B, Wiggers T, Meyer S, Van Der Heijde MN, Sloof MJH, Van De Velde CJH, Obertop H, Gouma DJ, Bruggink EDM, Lang JR Munting DK, Rutten APM, Rutten H, de Vries JE, Groot G, Zoutmulder HAN and van Putten WLJ (1992) Hepatic resections for colorectal metastases in The Netherlands. A multi-institutional 10-year study. Cancer 70: 28-34
52. Wagner JS, Adson MA, Van Heerden JA, Adson MH and Ilstrup DM (1984) The natural history of hepatic metastases from colorectal origin. A comparison with resective treatment. Ann Surg 199: 502-508
53. Watanabe N, Niitsu Y, Umeno H, Kuriyama H, Neda H, Yamauchi N, Maeda M and Urushizaki I (1988) Toxic effect of TNF on tumor vasculature in mice. Cancer Res 49: 2179-2183